1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

There are number of cancer therapies available for the patients in the market but most of the therapies that are available are associated with drawbacks. Chemotherapeutic drugs available for the cancer patients are prone to kill the heal...

Read More

---

Cervical Cancer Market to Experience Novel Combination Therapy Soon

Release Date: 04 November 2020

In case of recurrent or metastatic cervical cancer, immune checkpoint inhibitors as well as antibody-drug conjugates have shown promising results. 22% overall response rate was observed in the patients when given new PD-1 checkpoint bloc...

Read More

---

Scaffolding Leading to Decline in the Breast Cancer Recurrence Rate in the Patients

Release Date: 04 November 2020

A major limiting factor in most of the cancer therapies or treatment is the chances of cancer recurrence. But now novel findings from QUT study have found that a novel three-dimensional printed porous scaffold when combined with novel ch...

Read More

---

RELA to get Considered as Novel Potential Therapy Option for Brain Cancer

Release Date: 04 November 2020

Brain cancer is one of the most aggressive types of cancer which is very frightening for the researchers. But due to technological advancement made in the current pharmaceutical world, it has now become possible to understand and evaluat...

Read More

---

Emerging Cell Transfer Therapy for the Treatment of Patients Suffering from Solid Cancers

Release Date: 04 November 2020

In the past few years, T cell therapy has resulted in prolonged survival as well as treatment of the patients suffering from advanced solid tumors. Although the therapy is quite promising but the time taken by the T cells to start work a...

Read More

---

Novel ADC Technology to Increase Pancreatic Cancer Therapeutics Market by Substantial Rate

Release Date: 03 November 2020

It has been verified that the size of the tumor has a very strong impact on the overall survival rate in the patients suffering from pancreatic cancer. As per research findings, it has been observed that the overall survival rate in the ...

Read More

---

3D Ultramicroscopy to Indulge itself with Better Resolution of Cancer Microenvironment

Release Date: 03 November 2020

It is very important to analyze the left-over cancer cells after performing surgery in order to observe the chances of cancer recurrence in the patients. This respective parameter has now been taken into serious consideration as research...

Read More

---

Promising Therapy Options for Controlling High Grade Risk of Non-Muscle Invasive Bladder Cancer Patients

Release Date: 03 November 2020

It has been well observed that the high risk of cancer recurrence is based on the disease state in case of non-muscle invasive bladder cancer. Also, BCG has remained standard of care for these patients as there are scarcity of effective ...

Read More

---

Nanobiologics to Improve Trends and Opportunities for Cancer Patients

Release Date: 02 November 2020

A novel strategy called as nanobiologics is estimated to guide the immune cells of the system for the complete eradication of the tumor cells from the body of the patient. In general, nanobiologics are bioengineered tiny materials synthe...

Read More

---

Epigenetic Regulation Study for Controlling Growth of Prostate Cancer Cells

Release Date: 02 November 2020

Prostate cancer has become one of the most aggressive types of cancer as the cancer is not responding to any of the hormonal therapy. This respective research has been conducted by researchers from the University of Benn. The findings ha...

Read More

---

Novel BITE Technology Expressing Positive Impact on Prostate Cancer Patients

Release Date: 02 November 2020

The results for preliminary test for novel BiTEandreg; immuno-oncology therapy efficacy testing for patients with metastatic castration-resistant prostate cancer (mCRPC) who were already pre-treated were out and published at the virtual ...

Read More

---

Newly Discovered Fusion Proteins for Targeting Cancer

Release Date: 02 November 2020

The groundbreaking approval of the drug Gleevec (imatinib) in the year 2001 and further the identification chromosomal rearrangements that later on leads to oncogenic gene fusions has completely led to the transformation of the targeted ...

Read More

---

STAT3- Nanotechnology Targeting for Improving Mortality Rate for Aggressive Brain Cancer

Release Date: 02 November 2020

Nanoparticle based on human serum albumin developed by a group of researchers is now able to cross blood brain barrier in order to deliver the drugs for the treatment of glioblastoma cells. As per research conducted, it is observed that ...

Read More

---

FLX475 and Pembrolizumab to Expand the Cancer Therapeutics Market at Global Level

Release Date: 02 November 2020

As per the research findings, it is observed that the oral small molecule called as FLX475 alone or in combination with other immunotherapy drugs such as pembrolizumab in a phase andfrac12; dose-escalation and expansion study had an anti...

Read More

---

Breast Cancer Treatment to get Targeted by the Researchers from the University of Sussex

Release Date: 01 November 2020

Researchers have come across a unique set of mechanism of action which is capable of controlling the increasing prevalence rate due to breast cancer. A group of researchers at the University of Sussex have identified a novel target which...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |